Roubaix Capital »

Maxcyte shares owned by Roubaix Capital

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Roubaix Capital from 13F filings

Historical chart of Roubaix Capital investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by Roubaix Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by Roubaix Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 386k 4.70

More positions owned by Roubaix Capital

Sotera Health (SHC)
Genius Sports Shares Cl A (GENI)
Ftai Aviation SHS (FTAI)
MKS Instruments (MKSI)
Anterix Inc. Atex (ATEX)
Carpenter Technology Corporation (CRS)
Wright Express (WEX)
VSE Corporation (VSEC)
Biolife Solutions Com New (BLFS)
Park Aerospace Corp. Cmn Pke (PKE)
Orion Engineered Carbons (OEC)
Barnes (B)
Bio Rad Labs Cl A (BIO)
Sportradar Group Class A Ord Shs (SRAD)
Acv Auctions Com Cl A (ACVA)

View all positions for Roubaix Capital

Top funds holding Maxcyte

Cadian Capital Management
Vanguard Group
Vitruvian Partners
Millennium Management
Portolan Capital Management
Massachusetts Financial Services
Blue Water Life Science Advisors
River & Mercantile Asset Management
Arrowpoint Asset Management
Dimensional Fund Advisors
Willis Investment Counsel
Fred Alger Management
Roubaix Capital
Lazard Asset Management
Bank of New York Mellon

View all funds holding Maxcyte